Notice of AGM
Cizzle Biotechnology Holdings PLC has announced that its notice of Annual General Meeting has been posted to shareholders and will be available on the company's website, with the meeting scheduled for 11:00 a.m. on Tuesday, 16 June 2026. The company, a UK-based diagnostics developer focused on early cancer tests, is known for its CIZ1B biomarker technology for non-invasive lung cancer detection.
Select text to share a quote on X · sign in to keep highlights & notes in your CIZ notes
Cizzle Biotechnology, the UK based diagnostics developer of early cancer tests, announces that the Company's notice of Annual General Meeting has been posted to shareholders and will shortly be available for viewing on the Company's website at https://cizzlebiotechnology.com.
The Annual General Meeting will be held at 11:00 a.m. on Tuesday 16 June 2026 at the offices of Shakespeare Martineau LLP, C/O Ampa Holdings LLP, Level 19, The Shard, 32 London Bridge Street, London, United Kingdom, SE1 9SG.
You can also follow the Company through its twitter account @CizzlePlc and on LinkedIn.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.